Articles that cite
this article:
Endothelin-1 and Endothelin Receptor Antagonists as Potential Cardiovascular Therapeutic Agents
Adviye Ergul
phco 22(1):54. [CrossRef]
Influence of mechanical activity, adrenergic stimulation, and calcium on the expression of myosin heavy chains in cultivated neonatal cardiomyocytes
Hans Peter Luther, Simone Hille, Hannelore Haase, Ingo Morano
J Cell Biochem 64(3):458. [CrossRef]
Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats
Jan Kyselovic, Peter Krenek, Maurice Wibo, Théophile Godfraind
Br J Pharmacol 134(7):1516. [CrossRef]
Rapid Cardiac Growth Mechanical, Neural and Endocrine Dependence
Howard E. Morgan, Cathy J. Beinlich
Jpn Circ J 61(8):645. [CrossRef]
Development of endothelin receptor antagonists as potential therapeutic agents
Adviye Ergul
eotp 13(1):33. [CrossRef]
FP-receptor mediated trophic effects of prostanoids in rat ventricular cardiomyocytes
K Pönicke, C Giessler, M Grapow, I Heinroth-hoffmann, K Becker, B Osten, O-E Brodde
Br J Pharmacol 129(8):1723. [CrossRef]
Molecular Mechanism of Mechanical Stress-induced Cardiac Hypertrophy.
Issei Komuro
Jpn Heart J 41(2):117. [CrossRef]
Endothelin-1 Receptor Antagonist BQ123 Prevents Pulmonary Artery Hypertension Induced by Low Ambient Temperature in Broilers
Ying Yang, Jian Qiao, Zhenlong Wu, Yue Chen, Mingyu Gao, Deyuan Ou, Huiyu Wang
Biol Pharm Bull 28(12):2201. [CrossRef]
EFFECTS OF ENDOTHELIN-1 ON THE CONTRACTILITY OF CARDIOMYOCYTES FROM THE SPONTANEOUSLY HYPERTENSIVE RAT
Leanne M. Delbridge, Trefor O. Morgan, Peter J. Harris
Clin Exp Pharmacol Physiol 22(10):755. [CrossRef]
Intracellular Signaling and Genetic Reprogramming during Agonist-Induced Hypertrophy of Cardiomyocytes
H. A. A. Heugten, H. W. Jonge, K. Bezstarosti, H. S. Sharma, P. D. Verdouw, J. M. J. Lamers
Ann N Y Acad Sci 752(1 cardiac growt):343. [CrossRef]
IDENTIFICATION AND CHARACTERIZATION OF A DYSFUNCTIONAL CARDIAC MYOCYTE PHENOTYPE: ROLE OF BACTERIA, TOLL-LIKE RECEPTORS, AND ENDOTHELIN
Trupti A. Patel, Elizabeth Belcher, Timothy D. Warner, Si??n E. Harding, Jane A. Mitchell
28(4):434. [CrossRef]
Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension
Erika Berman rosenzweig, Robyn J Barst
Expert Opin Invest Drugs 10(5):811. [CrossRef]
Dynamics and Source of Endothelin-1 and Interleukin-6 Following Coronary Reperfusion in Patients with Acute Myocardial Infarction
Takahiro Imaizumi, Jun Nejima, Kaname Kiuchi, Shinhiro Takeda, Yoshihiko Seino, Keiji Tanaka, Teruo Takano
J Nippon Med Sch 74(2):131. [CrossRef]
Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist
R Tamler, N Bar-chama
Int J Impot Res 20(4):370. [CrossRef]
Endothelin in renal pathophysiology: From experimental to therapeutic application
Ton J Rabelink, Karin A H Kaasjager, Erik S G Stroes, Hein A Koomans
Kidney Int 50(6):1827. [CrossRef]
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, M. Kurabayashi
Eur Heart J 29(12):1485. [CrossRef]
Pitavastatin Improves Cardiac Function and Survival in Association With Suppression of the Myocardial Endothelin System in a Rat Model of Hypertensive Heart Failure
Masako Saka, Koji Obata, Sahoko Ichihara, Xian Wu Cheng, Hirotaka Kimata, Takao Nishizawa, Akiko Noda, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara
J Cardiovasc Pharmacol 47(6):770. [CrossRef]
Angiotensin II-dependent loss of cardiac function: Mechanisms and pharmacological targets attenuating this effect
Solaiman Mufti, Sibylle Wenzel, Gerhild Euler, Hans Michael Piper, Klaus-Dieter Schlüter
J Cell Physiol 217(1):242. [CrossRef]
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats
ALEXANDER V. Nabokov, KERSTIN Amann, SABINE Wessels, KLAUS Munter, JURGEN Wagner, EBERHARD Ritz
Kidney Int 55(2):512. [CrossRef]
FROM THE SARCOMERE TO THE NUCLEUS: Role of Genetics and Signaling in Structural Heart Disease
R. L. Nicol, N. Frey, E. N. Olson
Annu Rev Genom Human Genet 1(1):179. [CrossRef]
THE CELLULAR AND MOLECULAR RESPONSE OF CARDIAC MYOCYTES TO MECHANICAL STRESS
Junichi Sadoshima and, Seigo Izumo
Annu Rev Physiol 59(1):551. [CrossRef]
PATHOPHYSIOLOGY OF ENDOTHELIN IN THE CARDIOVASCULAR SYSTEM
Takashi Miyauchi, Tomoh Masaki
Annu Rev Physiol 61(1):391. [CrossRef]
Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium
Denise Hileeto, Mark Cukiernik, Suranjana Mukherjee, Terry Evans, Yousef Barbin, Donal Downey, Morris Karmazyn, Subrata Chakrabarti
Diabetes Metab Res Rev 18(5):386. [CrossRef]
INTERACTION BETWEEN ENDOTHELIN AND ANGIOTENSIN II
Paddy A Phillips
Clin Exp Pharmacol Physiol 26(7):517. [CrossRef]
Different remodelling against left ventricular overload between diabetic and non-diabetic haemodialysis patients
Masato Nishimura, Tetsuya Hashimoto, Hiroyuki Kobayashi, Toyofumi Fukukda, Koji Okino, Noriyuki Yamamoto, Naoto Nakamura, Toshikazu Yoshikawa, Hakuo Takahashi, Toshihiko Ono
Clin Exp Pharmacol Physiol 30(10):786. [CrossRef]
Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats
HR De smet, MF Menadue, JR Oliver, PA Phillips
Clin Exp Pharmacol Physiol 30(4):278. [CrossRef]
Endothelin Blockade In Angiotensin Ii Hypertension: Prevention And Treatment Studies In The Rat
Sylvia Ficai, Abderraouf Herizi, Albert Mimran, Bernard Jover
Clin Exp Pharmacol Physiol 28(12):1100. [CrossRef]
Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis
Masakazu Sano, Nozomi Ohuchi, Tomio Inoue, Kayoko Tono, Tetsuhiko Tachikawa, Yasuo Kizawa, Hajime Murakami
Fundam Clin Pharmacol 18(4):465. [CrossRef]
New Pharmacological Strategies in Chronic Heart Failure
van de Wal Rma, Voors Aa, Plokker Hwm, van Gilst Wh, van Veldhuisen Dj
Cardiovasc Drugs Ther 18(6):491. [CrossRef]
Molecular Mechanism of Cardiac Hypertrophy and Development
Issei Komuro
Jpn Circ J 65(5):353. [CrossRef]
Expressions of Bradykinin B2-Receptor, Kallikrein and Kininogen mRNAs in the Heart Are Altered in Pressure-Overload Cardiac Hypertrophy in Mice.
Katsutoshi Yayama, Hiromi Hiyoshi, Hiroshi Okamoto
Biol Pharm Bull 24(1):34. [CrossRef]
17β-estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells
Hong-Jye Hong, Ju-Chi Liu, Paul Chan, Shu-Hui Juan, Shih-Hurng Loh, Jaung-Geng Lin, Tzu-Hurng Cheng
J Biomed Sci 11(1):27. [CrossRef]
Functional Role of Endogenous Endothelin-1 in Congestive Heart Failure Treated with Angiotensin II Receptor Antagonist.
Kaoru Dohi, Katsuya Onishi, Tetsuya Kitamura, Tsutomu Okinaka, Masaaki Ito, Naoki Isaka, Takeshi Nakano
Jpn J Physiol 51(4):445. [CrossRef]
Deirdre Mullan, David Bell, Elizabeth Kelso, Barbara Mcdermott
J Cardiovasc Pharmacol 29(3):350. [CrossRef]
Shi-Juan Chen, Yiu-Fai Chen, Terry Opgenorth, Jerry Wessale, Qing Meng, Joan Durand, Vick Dicarlo, Suzanne Oparil
J Cardiovasc Pharmacol 29(6):713. [CrossRef]
Nathalie Delpech, Helene Soustre, Daniel Potreau
J Cardiovasc Pharmacol 29(1):136. [CrossRef]
Junichi Yoshida, Kazuhiro Yamamoto, Toshiaki Mano, Yasushi Sakata, Nagahiro Nishikawa, Takeshi Miwa, Masatsugu Hori, Tohru Masuyama
J Hypertens 21(2):437. [CrossRef]
Robert Willette, Karen Anderson, Allen Nelson, Alan Olzinski, Tina Woods, Robert Coatney, Nambi Aiyar, Eliot Ohlstein, Frank Barone
J Cardiovasc Pharmacol 38(4):606. [CrossRef]
Matthias Barton, Thomas Luscher
Curr Opin Nephrol Hypertens 8(5):549. [CrossRef]
Rita Holtwick, Hideo Baba, Elisabeth Ehler, Dorothee Risse, Melanie Vo, Joseph Gehrmann, Melanie Pierkes, Michaela Kuhn
J Cardiovasc Pharmacol 40(5):725. [CrossRef]
Nathalie Berthon, Pascal Laurant, Dominique Fellmann, Alain Berthelot
J Cardiovasc Pharmacol 42(1):24. [CrossRef]
Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist Losartan in rats
S. G. Spence, H. L. Allen, M. A. Cukierski, J. M. Manson, R. T. Robertson, R. S. Eydelloth
Teratol 51(6):367. [CrossRef]
Gian Rossi, Martina Cavallin, Damiano Rizzoni, Sergio Bova, Giuseppina Mazzocchi, Enrico Agabiti-rosei, Gastone Nussdorfer, Achille Pessina
J Hypertens 20(7):1451. [CrossRef]
Jan Kyselovic, Nicole Morel, Maurice Wibo, Theophile Godfraind
J Hypertens 16(10):1515. [CrossRef]
Ernesto Schiffrin
J Hypertens 16(12):1891. [CrossRef]
Endothelin as a Therapeutic Target in the Treatment of Cardiovascular Disease
Sukhdeep Kaur, William H. Frishman, Inderpal Singh, Praveen Tamirisa, Anil Kumar
Heart Dis 3(3):176. [CrossRef]
Endothelin, hypercholesterolemia and atherosclerosis
Matthias Barton, Tobias Traupe, Christian C. Haudenschild
Coron Artery Dis 14(7):477. [CrossRef]
Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart
Kazuhiro Yamamoto, Tohru Masuyama, Yasushi Sakata, Nagahiro Nishikawa, Toshiaki Mano, Masatsugu Hori
J Hypertens 20(4):753. [CrossRef]
Combination of ACE Inhibitors and Calcium Antagonists: A Logical Approach
Frank T. Ruschitzka, Georg Noll, Thomas F. L??scher
J Cardiovasc Pharmacol 31(supplement 2):S5. [CrossRef]
Endothelin-1 in the Heart During Exercise
Seiji Maeda, Takashi Miyauchi, Satoshi Sakai, Tsutomu Kobayashi, Katsutoshi Goto, Yasuro Sugishita, Mitsuo Matsuda
J Cardiovasc Pharmacol 31(supplement 1):S392. [CrossRef]
Endothelin-1 Expression in Hearts of Transgenic Hypertensive Mice Overexpressing Angiotensin II
Shinichi Maki, Takashi Miyauchi, Satoshi Sakai, Tsutomu Kobayashi, Seiji Maeda, Yoshiko Takata, Fumihiro Sugiyama, Akiyoshi Fukamizu, Kazuo Murakami, Katsutoshi Goto
J Cardiovasc Pharmacol 31(supplement 1):S412. [CrossRef]
Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat
R. R. Lamberts, R. J. Vaessen, N. Westerhof, G. J. M. Stienen
Basic Res Cardiol 102(1):19. [CrossRef]
Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics
Matthias Barton
Current Science Inc 2(1):84. [CrossRef]
The role of endothelin receptor antagonists in the treatment of chronic heart failure
Wolfgang Kiowski, Gabor Sütsch
Curr Cardiol Rep 3(3):232. [CrossRef]
BQ-123, A Selective Endothelin ETA Receptor Antagonist
Suzanne Moreland
Cardiovasc Drug Reviews 12(1):48. [CrossRef]
Ventricular unloading and myocyte recovery: Insight gained into the pathophysiology of congestive heart failure
Kenneth B. Margulies
Curr Cardiol Rep 2(3):181. [CrossRef]
The therapeutic potential of endothelin receptor antagonists in cardiovascular disease
Matthias Barton, Wolfgang Kiowski
Current Science Inc 3(4):322. [CrossRef]
Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy.
M. G. Castro, F. Rodríguez-pascual, N. Magán-marchal, J. R. Reguero, C. Alonso-montes, C. Morís, V. Alvarez, S. Lamas, E. Coto
Ann Hum Genet 71(5):601. [CrossRef]
Impaired angiotensin II–extracellular signal-regulated kinase signaling in failing human ventricular myocytes
Pietro Amedeo Modesti, Gian Gastone Neri Serneri, Tania Gamberi, Maria Boddi, Mirella Coppo, Gianluca Lucchese, Mario Chiavarelli, Giulia Bottai, Francesco Marino, Camilla Toz gensini
J Hypertens 26(10):2030. [CrossRef]
Effects of Carperitide on the Long-Term Prognosis of Patients With Acute Decompensated Chronic Heart Failure
Noritake Hata, Yoshihiko Seino, Takayoshi Tsutamoto, Shinya Hiramitsu, Noboru Kaneko, Tsutomu Yoshikawa, Hiroyuki Yokoyama, Keiji Tanaka, Kyoichi Mizuno, Jun Nejima
Circ J 72(11):1787. [CrossRef]
Expression and bioactivities of endothelin-1 in gingiva during cyclosporine A treatment
Y-T. Chin, H-P. Tu, Y-T. Chen, N-T. Dai, E-C. Shen, C-Y. Chiang, M. M-J. Fu, E. Fu
J Periodontal Res 44(1):35. [CrossRef]
Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis
T. Peltonen, P. Taskinen, J. Napankangas, H. Leskinen, P. Ohtonen, Y. Soini, T. Juvonen, J. Satta, O. Vuolteenaho, H. Ruskoaho
Eur Heart J 30(2):242. [CrossRef]
Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells
Klaus Pönicke, Ingrid Heinroth-hoffmann, Karin Becker, Otto-Erich Brodde
Br J Pharmacol 121(1):118. [CrossRef]
Development of Newer Calcium Channel Antagonists
Narutaka Ohashi, Hideo Mitamura, Satoshi Ogawa
Drug 69(1):21. [CrossRef]
The Pathological Role of Transient Receptor Potential Channels in Heart Disease
Hiroyuki Watanabe, Manabu Murakami, Takayoshi Ohba, Kyoichi Ono, Hiroshi Ito
Circ J 73(3):419. [CrossRef]
Differential Participation of Angiotensin II Type 1 and 2 Receptors in the Regulation of Cardiac Cell Death Triggered by Angiotensin II
Pablo Aránguiz-urroz, Dagoberto Soto, Ariel Contreras, Rodrigo Troncoso, Mario Chiong, José Montenegro, Daniel Venegas, Christian Smolic, Pedro Ayala, Walter G. Thomas
AM J HYPERTENS 22(5):569. [CrossRef]
